Leniolisib and Alpelisib: Interaction Details
- Alpelisib
- PiqrayVijoice
- Leniolisib
- Joenja
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Leniolisib and Alpelisib interaction:
What Happens When You Take Leniolisib With Alpelisib
What can happen when they are taken together (rated Major)
Increased exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Because leniolisib may raise the systemic exposure of drugs that are BCRP substrates, its use together with such agents should be avoided. When leniolisib was given with rosuvastatin, a BCRP substrate, in a drug interaction study, systemic exposure to rosuvastatin may have been increased 2-fold.1
The Leniolisib and Alpelisib Interaction, Explained
Leniolisib (Joenja) can block a natural 'pump' in your body called . This pump helps move certain medicines out of the body. Alpelisib (Piqray or Vijoice) is one of the medicines this pump handles. When leniolisib slows the pump, alpelisib can build up to higher levels than expected.
More alpelisib can mean more of its known side effects, such as high blood sugar, diarrhea, rash, and mouth sores. Because of this, the leniolisib label advises avoiding it with medicines like alpelisib. The good news is that your care team can plan around this. Please talk with your pharmacist or doctor before taking these two together.
Mechanism: Leniolisib inhibits (ABCG2)-mediated efflux. Alpelisib is a BCRP , so may increase alpelisib systemic exposure (/).
- Magnitude: Not studied with alpelisib. Leniolisib roughly doubled exposure of the BCRP probe rosuvastatin (about 2-fold).
- Onset: Unspecified. Evidence: Probable.
- Risk: Increased alpelisib toxicity, including , diarrhea, rash, stomatitis, and hypersensitivity.
- Management: Leniolisib labeling advises avoiding BCRP substrates. Consider alternative therapy. If coadministration is unavoidable, monitor closely for alpelisib adverse effects, particularly fasting glucose/HbA1c, tolerance, and skin reactions.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Leniolisib and Alpelisib Interact
The likely mechanism
of -mediated efflux transport by leniolisib
How to Manage the Leniolisib and Alpelisib Interaction
The for leniolisib advises avoiding it with medicines like alpelisib that rely on the pump. Your care team typically will:
- Review whether a different treatment plan could avoid using these two together.
- If both are truly needed, monitor you more closely for alpelisib side effects.
What you can do:
- Keep taking your medicines as prescribed. Do not stop or change anything on your own.
- Make sure every prescriber and your pharmacist know you take both.
- Report signs like increased thirst or urination, diarrhea, rash, or mouth sores.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Leniolisib or Alpelisib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: JOENJA oral tablets, leniolisib oral tablets
A drug interaction study found that giving leniolisib together with rosuvastatin (a ) may raise the systemic exposure of rosuvastatin by 2-fold.1
Leniolisib and Alpelisib: Common Questions
How serious is the Leniolisib and Alpelisib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Leniolisib and Alpelisib interaction managed?
The for leniolisib advises avoiding it with medicines like alpelisib that rely on the pump. Your care team typically will: Review whether a different treatment plan could avoid using these two together. If both are truly needed, monitor you more closely for alpelisib side effects. What you can do: Keep taking your medicines as prescribed. Do not stop or change anything… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Leniolisib and Alpelisib Interaction
Ask in your own words about taking Leniolisib and Alpelisib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: JOENJA(R) oral tablets, leniolisib oral tablets. Pharming Healthcare, Inc (per FDA), Warren, NJ, 2025. DailyMed
Other Serious Interactions of Leniolisib and Alpelisib
Also serious with Alpelisib
Also serious with Leniolisib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Alpelisib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 136 more
With Leniolisib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Green TeaModerate
- Black PepperModerate
- + 142 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.